Research and experimental development on natural sciences and engineering
FRACTA THERAPEUTICS AS
Revenue 2024
NOK 225,000
Operating profit
NOK 5,000
Equity
NOK 14,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
7.84
Equity ratio
87.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 2.1% | |
| Net margin (%%) | 2.0% | |
| Return on assets (%%) | 30.3% | |
| Likviditet | ||
| Current ratio | 7.84 | |
| Working capital | 14k | |
| Soliditet | ||
| Equity ratio (%%) | 87.3% | |
| Debt-to-equity ratio | 0.15 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.